Indiana’s BioPoly raising $2.3 million — is a product far behind?

Knee photo courtesy of FLickr user Larry PageFORT WAYNE, Indiana — Orthopedic device start up BioPoly is raising $2.3 million which will likely help bring its new prosthetic to market.

The device — called BioPoly RS (short for ReSurfacing) — only replaces the damaged portion of a joint. It’s made from a water-soluble polymer the company says mimics cartilage and egrates well with cartilage and joint tissue. Physicians could use the device to replace or resurface damaged tissue.

The company has raised about $500,000 so far, according to a filing with the Securities and Exchange Commission.

BioPoly, a subsidiary of Schwartz Biomedical, two years ago received $2 million from Indiana’s 21st Century Fund to develop the prosthetic and targeted 2009 for a market launch. That funding covered preclinical research and development, as well as the company’s Food and Drug Administration submission.

[Photo courtesy of Flickr user .LarryPage]

Reblog this post [with Zemanta]
Chris Seper

Chris Seper MedCity News

Chris Seper is the CEO and editor in chief at MedCity Media, which publishes MedCityNews.com. Reach him at chris@medcitynews.com.

more

Comments RSS Post a comment

[...] and Indiana. CoAxia raised $21.5 million to complete trial of stroke device, and it looks like BioPoly is on track to commercialize its prosthetic [...]

Comment by A tale of two researchers, MedCity Weekend Rounds June 26, 2009 : MedCity News — June 27, 2009 @ 3:07 pm

Post a Comment

Submit Comment

Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Twitter Buzz

MedCity Jobs Board

Real Time Web Analytics